Evidence map›Paper›PMID 26472224›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2015

Krüppel-like factor KLF10 deficiency predisposes to colitis through colonic macrophage dysregulation.

Konstantinos A Papadakis, James Krempski, Phyllis Svingen, Yuning Xiong, Olga F Sarmento, Gwen A Lomberk, Raul A Urrutia, William A Faubion

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Cells · 2025
    Review
  4. New Insights into the Role of KLF10 in Tissue Fibrosis.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Deciphering the Role ofJournal of biomedical science and engineering · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Konstantinos A PapadakisDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and papadakis.konstantinos@mayo.edu.
James KrempskiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Phyllis SvingenDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Yuning XiongDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Olga F SarmentoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Gwen A LomberkEpigenetics and Chromatin Dynamics Laboratory, Departments of Medicine and Biochemistry and Molecular Biology, Epigenetic Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Raul A UrrutiaEpigenetics and Chromatin Dynamics Laboratory, Departments of Medicine and Biochemistry and Molecular Biology, Epigenetic Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
William A FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; and.
Mayo Clinic · USWinnMed · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
KLF10 regulates colitis through mediating TGFb induction of FOXP3 in Treg cells.R01AI089714 · NIAID · MAYO CLINIC ROCHESTER · PI FAUBION, WILLIAM A · 2011 to 2025
$6.3M
Novel Experimental Therapeutics for Pancreatic CancerR01CA178627 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA178627NIAID NIH HHS R01 AI089714NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK052913NIDDK NIH HHS R01 DK52913
6 · The paper itself

Abstract

Krüppel-like factor (KLF)-10 is an important transcriptional regulator of TGF-β1 signaling in both CD8(+) and CD4(+) T lymphocytes. In the present study, we demonstrate a novel role for KLF10 in the regulation of TGFβRII expression with functional relevance in macrophage differentiation and activation. We first show that transfer of KLF10(-/-) bone marrow-derived macrophages into wild-type (WT) mice leads to exacerbation of experimental colitis. At the cell biological level, using two phenotypic strategies, we show that KLF10-deficient mice have an altered colonic macrophage phenotype with higher frequency of proinflammatory LyC6(+)MHCII(+) cells and a reciprocal decrease of the anti-inflammatory LyC6(-)MHCII(+) subset. Additionally, the anti-inflammatory CD11b(+)CX3CR1(hi) subset of colonic macrophages is significantly decreased in KLF10(-/-) compared with WT mice under inflammatory conditions. Molecularly, CD11b(+) colonic macrophages from KLF10(-/-) mice exhibit a proinflammatory cytokine profile with increased production of TNF-α and lower production of IL-10 in response to LPS stimulation. Because KLF10 is a transcription factor, we explored how this protein may regulate macrophage function. Consequently, we analyzed the expression of TGFβRII expression in colonic macrophages and found that, in the absence of KLF10, macrophages express lower levels of TGFβRII and display an attenuated Smad-2 phosphorylation following TGF-β1 stimulation. We further show that KLF10 directly binds to the TGFβRII promoter in macrophages, leading to enhanced gene expression through histone H3 acetylation. Collectively, our data reveal a critical role for KLF10 in the epigenetic regulation of TGFβRII expression in macrophages and the acquisition of a "regulatory" phenotype that contributes to intestinal mucosal homeostasis.

Indexed as

AcetylationAnimalsBase SequenceBinding SitesCD11b AntigenColitisColonCX3C Chemokine Receptor 1Dextran SulfateDisease Models, AnimalEarly Growth Response Transcription FactorsGenetic Predisposition to DiseaseHistocompatibility Antigens Class IIHistonesInflammation MediatorsInterleukin-10CD11b AntigenCX3C Chemokine Receptor 1Cx3cr1 protein, mouseDextran SulfateEarly Growth Response Transcription FactorsHistocompatibility Antigens Class IIHistonesIL10 protein, mouseInflammation MediatorsInterleukin-10KLF10 protein, mouseKruppel-Like Transcription FactorsProtein Serine-Threonine KinasesReceptors, ChemokineReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IISmad2 ProteinSmad2 protein, mouseTumor Necrosis Factor-alphacolitiscolonic macrophagesepigeneticshistone acetyl transferaseKrüppel-like factor

Identifiers

PMID26472224
PMCPMC4669350
OpenAlexW2297123167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.